Europe Golimumab Market Report 2016

November 2016 | 103 pages | ID: E5F5E9C5110EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Golimumab

Revenue, means the sales value of Golimumab

This report studies sales (consumption) of Golimumab in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

• Pfizer
• GlaxoSmithKline
• Sandoz
• Celltrion
• Janssen Biotech
• Bionovis
• Reliance Life Sciences
• AryoGen Biopharma
• Simcere Pharmaceutical
• Samsung Bioepis

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Golimumab in these countries, from 2011 to 2021 (forecast), like

• Germany
• France
• UK
• Russia
• Italy
• Spain
• Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by application, this report focuses on sales, market share and growth rate of Golimumab in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Europe Golimumab Market Report 2016

1 GOLIMUMAB OVERVIEW

1.1 Product Overview and Scope of Golimumab
1.2 Classification of Golimumab
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Golimumab
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Golimumab Market by Countries
  1.4.1 Germany Status and Prospect (2011-2021)
  1.4.2 France Status and Prospect (2011-2021)
  1.4.3 UK Status and Prospect (2011-2021)
  1.4.4 Russia Status and Prospect (2011-2021)
  1.4.5 Italy Status and Prospect (2011-2021)
  1.4.6 Spain Status and Prospect (2011-2021)
  1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Golimumab (2011-2021)
  1.5.1 Europe Golimumab Sales and Growth Rate (2011-2021)
  1.5.2 Europe Golimumab Revenue and Growth Rate (2011-2021)

2 EUROPE GOLIMUMAB BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe Golimumab Market Competition by Manufacturers
  2.1.1 Europe Golimumab Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe Golimumab Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Golimumab (Volume and Value) by Type
  2.2.1 Europe Golimumab Sales and Market Share by Type (2011-2016)
  2.2.2 Europe Golimumab Revenue and Market Share by Type (2011-2016)
2.3 Europe Golimumab (Volume and Value) by Countries
  2.3.1 Europe Golimumab Sales and Market Share by Countries (2011-2016)
  2.3.2 Europe Golimumab Revenue and Market Share by Countries (2011-2016)
2.4 Europe Golimumab (Volume) by Application

3 GERMANY GOLIMUMAB (VOLUME, VALUE AND SALES PRICE)

3.1 Germany Golimumab Sales and Value (2011-2016)
  3.1.1 Germany Golimumab Sales and Growth Rate (2011-2016)
  3.1.2 Germany Golimumab Revenue and Growth Rate (2011-2016)
  3.1.3 Germany Golimumab Sales Price Trend (2011-2016)
3.2 Germany Golimumab Sales and Market Share by Manufacturers
3.3 Germany Golimumab Sales and Market Share by Type
3.4 Germany Golimumab Sales and Market Share by Application

4 FRANCE GOLIMUMAB (VOLUME, VALUE AND SALES PRICE)

4.1 France Golimumab Sales and Value (2011-2016)
  4.1.1 France Golimumab Sales and Growth Rate (2011-2016)
  4.1.2 France Golimumab Revenue and Growth Rate (2011-2016)
  4.1.4 France Golimumab Sales Price Trend (2011-2016)
4.2 France Golimumab Sales and Market Share by Manufacturers
4.3 France Golimumab Sales and Market Share by Type
4.4 France Golimumab Sales and Market Share by Application

5 UK GOLIMUMAB (VOLUME, VALUE AND SALES PRICE)

5.1 UK Golimumab Sales and Value (2011-2016)
  5.1.1 UK Golimumab Sales and Growth Rate (2011-2016)
  5.1.2 UK Golimumab Revenue and Growth Rate (2011-2016)
  5.1.5 UK Golimumab Sales Price Trend (2011-2016)
5.2 UK Golimumab Sales and Market Share by Manufacturers
5.3 UK Golimumab Sales and Market Share by Type
5.4 UK Golimumab Sales and Market Share by Application

6 RUSSIA GOLIMUMAB (VOLUME, VALUE AND SALES PRICE)

6.1 Russia Golimumab Sales and Value (2011-2016)
  6.1.1 Russia Golimumab Sales and Growth Rate (2011-2016)
  6.1.2 Russia Golimumab Revenue and Growth Rate (2011-2016)
  6.1.6 Russia Golimumab Sales Price Trend (2011-2016)
6.2 Russia Golimumab Sales and Market Share by Manufacturers
6.3 Russia Golimumab Sales and Market Share by Type
6.4 Russia Golimumab Sales and Market Share by Application

7 ITALY GOLIMUMAB (VOLUME, VALUE AND SALES PRICE)

7.1 Italy Golimumab Sales and Value (2011-2016)
  7.1.1 Italy Golimumab Sales and Growth Rate (2011-2016)
  7.1.2 Italy Golimumab Revenue and Growth Rate (2011-2016)
  7.1.7 Italy Golimumab Sales Price Trend (2011-2016)
7.2 Italy Golimumab Sales and Market Share by Manufacturers
7.3 Italy Golimumab Sales and Market Share by Type
7.4 Italy Golimumab Sales and Market Share by Application

8 SPAIN GOLIMUMAB (VOLUME, VALUE AND SALES PRICE)

8.1 Spain Golimumab Sales and Value (2011-2016)
  8.1.1 Spain Golimumab Sales and Growth Rate (2011-2016)
  8.1.2 Spain Golimumab Revenue and Growth Rate (2011-2016)
  8.1.8 Spain Golimumab Sales Price Trend (2011-2016)
8.2 Spain Golimumab Sales and Market Share by Manufacturers
8.3 Spain Golimumab Sales and Market Share by Type
8.4 Spain Golimumab Sales and Market Share by Application

9 BENELUX GOLIMUMAB (VOLUME, VALUE AND SALES PRICE)

9.1 Benelux Golimumab Sales and Value (2011-2016)
  9.1.1 Benelux Golimumab Sales and Growth Rate (2011-2016)
  9.1.2 Benelux Golimumab Revenue and Growth Rate (2011-2016)
  9.1.9 Benelux Golimumab Sales Price Trend (2011-2016)
9.2 Benelux Golimumab Sales and Market Share by Manufacturers
9.3 Benelux Golimumab Sales and Market Share by Type
9.4 Benelux Golimumab Sales and Market Share by Application

10 EUROPE GOLIMUMAB MANUFACTURERS ANALYSIS

10.1 Pfizer
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Golimumab Product Type, Application and Specification
    10.1.2.1 Type I
    10.1.2.2 Type II
  10.1.3 Pfizer Golimumab Sales, Revenue, Price and Gross Margin (2011-2016)
  10.1.4 Main Business/Business Overview
10.2 GlaxoSmithKline
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Golimumab Product Type, Application and Specification
    10.2.2.1 Type I
    10.2.2.2 Type II
  10.2.3 GlaxoSmithKline Golimumab Sales, Revenue, Price and Gross Margin (2011-2016)
  10.2.4 Main Business/Business Overview
10.3 Sandoz
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Golimumab Product Type, Application and Specification
    10.3.2.1 Type I
    10.3.2.2 Type II
  10.3.3 Sandoz Golimumab Sales, Revenue, Price and Gross Margin (2011-2016)
  10.3.4 Main Business/Business Overview
10.4 Celltrion
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Golimumab Product Type, Application and Specification
    10.4.2.1 Type I
    10.4.2.2 Type II
  10.4.3 Celltrion Golimumab Sales, Revenue, Price and Gross Margin (2011-2016)
  10.4.4 Main Business/Business Overview
10.5 Janssen Biotech
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Golimumab Product Type, Application and Specification
    10.5.2.1 Type I
    10.5.2.2 Type II
  10.5.3 Janssen Biotech Golimumab Sales, Revenue, Price and Gross Margin (2011-2016)
  10.5.4 Main Business/Business Overview
10.6 Bionovis
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Golimumab Product Type, Application and Specification
    10.6.2.1 Type I
    10.6.2.2 Type II
  10.6.3 Bionovis Golimumab Sales, Revenue, Price and Gross Margin (2011-2016)
  10.6.4 Main Business/Business Overview
10.7 Reliance Life Sciences
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Golimumab Product Type, Application and Specification
    10.7.2.1 Type I
    10.7.2.2 Type II
  10.7.3 Reliance Life Sciences Golimumab Sales, Revenue, Price and Gross Margin (2011-2016)
  10.7.4 Main Business/Business Overview
10.8 AryoGen Biopharma
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Golimumab Product Type, Application and Specification
    10.8.2.1 Type I
    10.8.2.2 Type II
  10.8.3 AryoGen Biopharma Golimumab Sales, Revenue, Price and Gross Margin (2011-2016)
  10.8.4 Main Business/Business Overview
10.9 Simcere Pharmaceutical
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Golimumab Product Type, Application and Specification
    10.9.2.1 Type I
    10.9.2.2 Type II
  10.9.3 Simcere Pharmaceutical Golimumab Sales, Revenue, Price and Gross Margin (2011-2016)
  10.9.4 Main Business/Business Overview
10.10 Samsung Bioepis
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Golimumab Product Type, Application and Specification
    10.10.2.1 Type I
    10.10.2.2 Type II
  10.10.3 Samsung Bioepis Golimumab Sales, Revenue, Price and Gross Margin (2011-2016)
  10.10.4 Main Business/Business Overview

11 GOLIMUMAB MANUFACTURING COST ANALYSIS

11.1 Golimumab Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Golimumab

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Golimumab Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Golimumab Major Manufacturers in 2015
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 EUROPE GOLIMUMAB MARKET FORECAST (2016-2021)

14.1 Germany Golimumab Sales Forecast (2016-2021)
14.2 France Golimumab Sales Forecast (2016-2021)
14.3 UK Golimumab Sales Forecast (2016-2021)
14.4 Russia Golimumab Sales Forecast (2016-2021)
14.5 Italy Golimumab Sales Forecast (2016-2021)
14.6 Spain Golimumab Sales Forecast (2016-2021)
14.7 Benelux Golimumab Sales Forecast (2016-2021)
14.8 Europe Golimumab Sales Forecast by Type (2016-2021)
14.9 Europe Golimumab Sales Forecast by Application (2016-2021)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Golimumab
Table Classification of Golimumab
Figure Europe Sales Market Share of Golimumab by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Application of Golimumab
Figure Europe Sales Market Share of Golimumab by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Germany Golimumab Revenue and Growth Rate (2011-2021)
Figure France Golimumab Revenue and Growth Rate (2011-2021)
Figure UK Golimumab Revenue and Growth Rate (2011-2021)
Figure Russia Golimumab Revenue and Growth Rate (2011-2021)
Figure Italy Golimumab Revenue and Growth Rate (2011-2021)
Figure Spain Golimumab Revenue and Growth Rate (2011-2021)
Figure Benelux Golimumab Revenue and Growth Rate (2011-2021)
Figure Europe Golimumab Sales and Growth Rate (2011-2021)
Figure Europe Golimumab Revenue and Growth Rate (2011-2021)
Table Europe Golimumab Sales of Key Manufacturers (2015 and 2016)
Table Europe Golimumab Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Golimumab Sales Share by Manufacturers
Figure 2016 Golimumab Sales Share by Manufacturers
Table Europe Golimumab Revenue by Manufacturers (2015 and 2016)
Table Europe Golimumab Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Golimumab Revenue Share by Manufacturers
Table 2016 Europe Golimumab Revenue Share by Manufacturers
Table Europe Golimumab Sales and Market Share by Type (2011-2016)
Table Europe Golimumab Sales Share by Type (2011-2016)
Figure Sales Market Share of Golimumab by Type (2011-2016)
Figure Europe Golimumab Sales Growth Rate by Type (2011-2016)
Table Europe Golimumab Revenue and Market Share by Type (2011-2016)
Table Europe Golimumab Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Golimumab by Type (2011-2016)
Figure Europe Golimumab Revenue Growth Rate by Type (2011-2016)
Table Europe Golimumab Sales and Market Share by Countries (2011-2016)
Table Europe Golimumab Sales Share by Countries (2011-2016)
Figure Sales Market Share of Golimumab by Countries (2011-2016)
Table Europe Golimumab Revenue and Market Share by Countries (2011-2016)
Table Europe Golimumab Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Golimumab by Countries (2011-2016)
Table Europe Golimumab Sales and Market Share by Application (2011-2016)
Table Europe Golimumab Sales Share by Application (2011-2016)
Figure Sales Market Share of Golimumab by Application (2011-2016)
Figure Germany Golimumab Sales and Growth Rate (2011-2016)
Figure Germany Golimumab Revenue and Growth Rate (2011-2016)
Figure Germany Golimumab Sales Price Trend (2011-2016)
Table Germany Golimumab Sales by Manufacturers (2015 and 2016)
Table Germany Golimumab Market Share by Manufacturers (2015 and 2016)
Table Germany Golimumab Sales by Type (2015 and 2016)
Table Germany Golimumab Market Share by Type (2015 and 2016)
Table Germany Golimumab Sales by Application (2015 and 2016)
Table Germany Golimumab Market Share by Application (2015 and 2016)
Figure France Golimumab Sales and Growth Rate (2011-2016)
Figure France Golimumab Revenue and Growth Rate (2011-2016)
Figure France Golimumab Sales Price Trend (2011-2016)
Table France Golimumab Sales by Manufacturers (2015 and 2016)
Table France Golimumab Market Share by Manufacturers (2015 and 2016)
Table France Golimumab Sales by Type (2015 and 2016)
Table France Golimumab Market Share by Type (2015 and 2016)
Table France Golimumab Sales by Application (2015 and 2016)
Table France Golimumab Market Share by Application (2015 and 2016)
Figure UK Golimumab Sales and Growth Rate (2011-2016)
Figure UK Golimumab Revenue and Growth Rate (2011-2016)
Figure UK Golimumab Sales Price Trend (2011-2016)
Table UK Golimumab Sales by Manufacturers (2015 and 2016)
Table UK Golimumab Market Share by Manufacturers (2015 and 2016)
Table UK Golimumab Sales by Type (2015 and 2016)
Table UK Golimumab Market Share by Type (2015 and 2016)
Table UK Golimumab Sales by Application (2015 and 2016)
Table UK Golimumab Market Share by Application (2015 and 2016)
Figure Russia Golimumab Sales and Growth Rate (2011-2016)
Figure Russia Golimumab Revenue and Growth Rate (2011-2016)
Figure Russia Golimumab Sales Price Trend (2011-2016)
Table Russia Golimumab Sales by Manufacturers (2015 and 2016)
Table Russia Golimumab Market Share by Manufacturers (2015 and 2016)
Table Russia Golimumab Sales by Type (2015 and 2016)
Table Russia Golimumab Market Share by Type (2015 and 2016)
Table Russia Golimumab Sales by Application (2015 and 2016)
Table Russia Golimumab Market Share by Application (2015 and 2016)
Figure Italy Golimumab Sales and Growth Rate (2011-2016)
Figure Italy Golimumab Revenue and Growth Rate (2011-2016)
Figure Italy Golimumab Sales Price Trend (2011-2016)
Table Italy Golimumab Sales by Manufacturers (2015 and 2016)
Table Italy Golimumab Market Share by Manufacturers (2015 and 2016)
Table Italy Golimumab Sales by Type (2015 and 2016)
Table Italy Golimumab Market Share by Type (2015 and 2016)
Table Italy Golimumab Sales by Application (2015 and 2016)
Table Italy Golimumab Market Share by Application (2015 and 2016)
Figure Spain Golimumab Sales and Growth Rate (2011-2016)
Figure Spain Golimumab Revenue and Growth Rate (2011-2016)
Figure Spain Golimumab Sales Price Trend (2011-2016)
Table Spain Golimumab Sales by Manufacturers (2015 and 2016)
Table Spain Golimumab Market Share by Manufacturers (2015 and 2016)
Table Spain Golimumab Sales by Type (2015 and 2016)
Table Spain Golimumab Market Share by Type (2015 and 2016)
Table Spain Golimumab Sales by Application (2015 and 2016)
Table Spain Golimumab Market Share by Application (2015 and 2016)
Figure Benelux Golimumab Sales and Growth Rate (2011-2016)
Figure Benelux Golimumab Revenue and Growth Rate (2011-2016)
Figure Benelux Golimumab Sales Price Trend (2011-2016)
Table Benelux Golimumab Sales by Manufacturers (2015 and 2016)
Table Benelux Golimumab Market Share by Manufacturers (2015 and 2016)
Table Benelux Golimumab Sales by Type (2015 and 2016)
Table Benelux Golimumab Market Share by Type (2015 and 2016)
Table Benelux Golimumab Sales by Application (2015 and 2016)
Table Benelux Golimumab Market Share by Application (2015 and 2016)
Table Golimumab Basic Information List
Table Pfizer Golimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Golimumab Sales Market Share (2011-2016)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Golimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Golimumab Sales Market Share (2011-2016)
Table Sandoz Basic Information List
Table Sandoz Golimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sandoz Golimumab Sales Market Share (2011-2016)
Table Celltrion Basic Information List
Table Celltrion Golimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Celltrion Golimumab Sales Market Share (2011-2016)
Table Janssen Biotech Basic Information List
Table Janssen Biotech Golimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Janssen Biotech Golimumab Sales Market Share (2011-2016)
Table Bionovis Basic Information List
Table Bionovis Golimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bionovis Golimumab Sales Market Share (2011-2016)
Table Reliance Life Sciences Basic Information List
Table Reliance Life Sciences Golimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Reliance Life Sciences Golimumab Sales Market Share (2011-2016)
Table AryoGen Biopharma Basic Information List
Table AryoGen Biopharma Golimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table AryoGen Biopharma Golimumab Sales Market Share (2011-2016)
Table Simcere Pharmaceutical Basic Information List
Table Simcere Pharmaceutical Golimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Simcere Pharmaceutical Golimumab Sales Market Share (2011-2016)
Table Samsung Bioepis Basic Information List
Table Samsung Bioepis Golimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Samsung Bioepis Golimumab Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Golimumab
Figure Manufacturing Process Analysis of Golimumab
Figure Golimumab Industrial Chain Analysis
Table Raw Materials Sources of Golimumab Major Manufacturers in 2015
Table Major Buyers of Golimumab
Table Distributors/Traders List
Figure Germany Golimumab Sales and Growth Rate Forecast (2016-2021)
Figure Germany Golimumab Revenue and Growth Rate Forecast (2016-2021)
Figure France Golimumab Sales and Growth Rate Forecast (2016-2021)
Figure France Golimumab Revenue and Growth Rate Forecast (2016-2021)
Figure UK Golimumab Sales and Growth Rate Forecast (2016-2021)
Figure UK Golimumab Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Golimumab Sales and Growth Rate Forecast (2016-2021)
Figure Russia Golimumab Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Golimumab Sales and Growth Rate Forecast (2016-2021)
Figure Italy Golimumab Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Golimumab Sales and Growth Rate Forecast (2016-2021)
Figure Spain Golimumab Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Golimumab Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Golimumab Revenue and Growth Rate Forecast (2016-2021)
Table Europe Golimumab Sales Forecast by Type (2016-2021)
Table Europe Golimumab Sales Forecast by Application (2016-2021)